Quang X Pham - CVKD / Cadrenal Therapeutics, Inc. - Insider Trade Report

Insider Purchases - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made by Quang X Pham in CVKD / Cadrenal Therapeutics, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date	Reported Shares	Reported Price	Adjusted Shares	Adjusted Price	Cost Basis	Days to Max	Price at Max	Max Profit ($)	Max Return (%)
2023-09-05	20,000	0.9100	1,333	13.6500	18,200	365	8.1900	-7,283	-40.02
2023-09-05	20,000	0.8994	1,333	13.4910	17,988
2023-09-01	10,000	0.9318	667	13.9770	9,318
2023-09-01	20,000	0.9291	1,333	13.9365	18,582
2023-09-01	20,000	0.9222	1,333	13.8330	18,444
2023-09-01	10,000	0.9168	667	13.7520	9,168
2023-09-01	10,000	0.8433	667	12.6495	8,433

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

Insider Sales - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made by Quang X Pham in CVKD / Cadrenal Therapeutics, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date	Reported Shares	Reported Price	Adjusted Shares	Adjusted Price	Cost Basis	Days to Min	Price at Min	Max Loss Avoided ($)	Max Loss Avoided (%)
2025-10-13	1,800	14.1500	1,800	14.1500	25,470	233	4.1900	-17,928	-70.39
2025-10-09	1,800	14.0200	1,800	14.0200	25,236
2025-10-02	500	14.1300	500	14.1300	7,065
2025-10-01	881	14.0100	881	14.0100	12,343
2025-09-29	419	14.0100	419	14.0100	5,870
2025-09-25	6,790	14.0900	6,790	14.0900	95,671
2025-09-24	2,581	13.9900	2,581	13.9900	36,108
2025-08-28	1,193	13.9900	1,193	13.9900	16,690
2025-08-27	3,836	13.9900	3,836	13.9900	53,666

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

Insider Transaction History